(AlphaS,BetaR)-Bedaquiline (TRC-B119540-1MG)
(alphaS)-alpha-Amino-N-[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]benzenepropanamide Hydrochloride (Bortezomib Intermediate II) (MM3368.04-0025)
(4R)-4-(Ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e]-1,2-thiazine-6-(N-methylsulfonyl)sulfonamide 1,1-Dioxide (Brinzolamide Methanesulfonimide Analogue) (MM1300.06)
(AlphaR,BetaS)-rel-Bedaquiline (TRC-B119555-10MG)
(AlphaR)-Alpha-Methyl-N-[[3-(trifluoromethyl)phenyl]methyl]-1-naphthalenemethanamine Hydrochloride (TRC-M330950-10MG)
(AlphaR)-Alpha-Methyl-N-[3-(3-methylphenyl)propyl]-1-naphthalenemethanamine Hydrochloride (TRC-M322070-10MG)
(all-Z)-6,9,12,15,18-Heneicosapentaenoic Acid Methyl Ester (TRC-H245615-2.5MG)
(all-Z)-6,9,12,15,18-Heneicosapentaenoic Acid Methyl Ester (TRC-H245615-1MG)
(all-Z)-6,9,12,15,18-Heneicosapentaenoic Acid Ethyl Ester (TRC-H245610-10MG)
(all-Z)-6,9,12,15,18-Heneicosapentaenoic Acid Ethyl Ester (TRC-H245610-1MG)
This site uses cookies. Visit our Privacy Policy page to find out more about our use of cookies and how to opt out.
